Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 8, Pages -
Publisher
Springer Nature
Online
2018-07-26
DOI
10.1038/s41419-018-0811-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack
- (2017) Pritish Nilendu et al. INTERNATIONAL JOURNAL OF CANCER
- An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
- (2017) Deyong Jia et al. Cell Death & Disease
- Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors
- (2017) Andrew Sulaiman et al. Oncotarget
- Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia
- (2016) Hyunggyun Noh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition
- (2016) Andrew Sulaiman et al. FEBS LETTERS
- PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer
- (2016) Jennifer M. Spangle et al. Cell Reports
- mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
- (2015) Govindasamy-Muralidharan Karthik et al. CANCER LETTERS
- Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs
- (2015) Xiaoyan Ning et al. CELL CYCLE
- Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
- (2015) P. Wang et al. CLINICAL CANCER RESEARCH
- HDAC5-mTORC1 Interaction in Differential Regulation of Ghrelin and Nucleobindin 2 (NUCB2)/Nesfatin-1
- (2015) Liangxiao Ma et al. MOLECULAR ENDOCRINOLOGY
- Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1
- (2015) Shiwen Wang et al. PLOS BIOLOGY
- Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
- (2015) Sylvie Maubant et al. PLoS One
- HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts
- (2014) Patricia de Cremoux et al. BREAST CANCER RESEARCH AND TREATMENT
- Emerging strategies to overcome resistance to endocrine therapy for breast cancer
- (2014) M. Firdos Ziauddin et al. CANCER AND METASTASIS REVIEWS
- Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors
- (2014) K. Dayekh et al. MOLECULAR CANCER THERAPEUTICS
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
- (2014) Stina M. Singel et al. NEOPLASIA
- Adenoid cystic carcinoma of breast: Recent advances
- (2014) Kosuke Miyai World Journal of Clinical Cases
- Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials
- (2013) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Everolimus: side effect profile and management of toxicities in breast cancer
- (2013) Elisavet Paplomata et al. BREAST CANCER RESEARCH AND TREATMENT
- Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
- (2013) G S Ducker et al. ONCOGENE
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- Reactivation of Estrogen Receptor α by Vorinostat Sensitizes Mesenchymal-Like Triple-Negative Breast Cancer to Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor
- (2013) Karri Stark et al. PLoS One
- Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
- (2013) Scott Thomas et al. PLoS One
- Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
- (2012) Andrea Cavazzoni et al. CANCER LETTERS
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
- (2012) B. Ramaswamy et al. CANCER RESEARCH
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- NCBI GEO: archive for functional genomics data sets—update
- (2012) Tanya Barrett et al. NUCLEIC ACIDS RESEARCH
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
- (2011) Seth A. Wander et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- p53 Binds to Estrogen Receptor 1 Promoter in Human Breast Cancer Cells
- (2011) Mozhgan Rasti et al. PATHOLOGY & ONCOLOGY RESEARCH
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HDAC2 Promotes eIF4E Sumoylation and Activates mRNA Translation Gene Specifically
- (2010) Xiang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter
- (2009) S. J. Ellison-Zelski et al. MOLECULAR AND CELLULAR BIOLOGY
- A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
- (2008) M J Scandlyn et al. BRITISH JOURNAL OF CANCER
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
- (2008) A. Y. Choo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search